Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
70°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Eli Lilly
(NY:
LLY
)
771.12
-15.90 (-2.02%)
Official Closing Price
Updated: 7:00 PM EDT, May 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Eli Lilly
< Previous
1
2
...
12
13
14
15
16
17
18
19
20
...
78
79
Next >
SPDR ETF Report For Tuesday, February 6
February 07, 2024
In this video, Ira Epstein reviews the day's trading in various SPDR-ETF markets for the trading day just ended, Tuesday, February 6
Via
Talk Markets
Topics
ETFs
Eli Lilly (LLY) Q4 2023 Earnings Call Transcript
February 06, 2024
LLY earnings call for the period ending December 31, 2023.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
The Top 25 Stocks to Buy Immediately According to AI: February 2024 Edition
February 06, 2024
Some of the best stocks to buy in February according to MarketMaster AI suggest that a major economic recovery is underway.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Eli Lilly, Novo Nordisk Could Be First Trillion-Dollar Drug Stocks
February 06, 2024
Thanks to weight loss and obesity drugs, Eli Lilly and Novo Nordisk could become the first trillion-dollar stocks in the pharma industry.
Via
InvestorPlace
Earnings Scheduled For February 6, 2024
February 06, 2024
Companies Reporting Before The Bell • BP (NYSE:BP) is projected to report quarterly earnings at $1.05 per share on revenue of $53.50 billion.
Via
Benzinga
In-Depth Analysis: Eli Lilly Versus Competitors In Pharmaceuticals Industry
February 05, 2024
Via
Benzinga
Is It Too Late to Buy Eli Lilly Stock?
February 05, 2024
Growth may slow, and its valuation is looking precarious.
Via
The Motley Fool
Tech Slides, Chinese Stocks Rebound, New York Community Bancorp Tumbles: What's Driving Markets Tuesday?
February 06, 2024
At noon trading in New York, major equity indices on Wall Street remain directionless as traders evaluate the future course of monetary policy ahead of several speeches by Federal Reserve officials in...
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Why Eli Lilly Stock Jumped as Much as 5.1% Today Then Gave Up Its Gains
February 06, 2024
Investors shouldn't worry that Lilly's gains quickly evaporated.
Via
The Motley Fool
Stocks In China Flying, Lifting Sentiment In Stock Markets Across The Globe, AI And Weight Loss Drugs Get Hotter
February 06, 2024
To gain an edge, this is what you need to know today.
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Chips Vs. Oil: Nvidia Now Outweighs The S&P 500's Entire Energy Sector
February 06, 2024
Nvidia now has a market cap more than the combined value of the S&P 500 energy sector.
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
Dow Jumps Over 100 Points; Eli Lilly Posts Upbeat Earnings
February 06, 2024
U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 100 points on Tuesday. Following the market opening Tuesday, the Dow traded up 0.34% to 38,509.84 while the NASDAQ...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Eli Lilly Soars On Diabetes And Obesity Drug Boom, Projects 20% Revenue Increase In 2024
February 06, 2024
This surge is attributed to the popularity of Lilly's new diabetes drug, Mounjaro, and its anti-obesity medication, Zepbound.
Via
Benzinga
Investors Cheer Eli Lilly Earnings, Q4 Performance Surpasses Expectations Thanks To Strong Zepbound Launch, Surging Weight Loss Drug Sales
February 06, 2024
Eli Lilly beats Q4 2023 revenue expectations at $9.35 billion, driven by higher realized prices and strong sales of Mounjaro, Verzenio, and Jardiance.
Via
Benzinga
US Stocks Brace For Another Day In The Red As Rally Loses Steam: Analyst Sees Market Pullback On This Indicator
February 06, 2024
The stock rally that propelled the S&P 500 and the Dow to record highs last week seems to have stalled, with Fed officials remaining non-committal about rate-cut plans.
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Eli Lilly Stock Veers Higher On Fourth-Quarter Beat
February 06, 2024
Eli Lilly Scored a strong Q4 win and provided healthy guidance Tuesday. Shares moved toward a profit-taking zone following a January breakout.
Via
Investor's Business Daily
Investor Sentiment Improves Following Services PMI; S&P 500 Slips From Record Levels
February 06, 2024
The CNN Money Fear and Greed index showed further improvement in overall market sentiment, but it remained in the "Greed" zone on Monday. U.S. stocks closed lower on Monday, with the S&P 500 index...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Ford, Eli Lilly And 3 Stocks To Watch Heading Into Tuesday
February 06, 2024
With U.S. stock futures trading mixed this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:
Via
Benzinga
Eli Lilly Likely To Report Higher Q4 Earnings; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
February 06, 2024
Eli Lilly and Company (NYSE: LLY) is expected to release earnings results for its fourth quarter, before the opening bell on Feb. 6, 2024.
Via
Benzinga
Markets Take A Powder; PLTR, NXPI Beat In Q4
February 06, 2024
We finished the normal trading session on the first day of a new trading week the same way we began it — reluctant to drag a stock market higher amid all-time high ranges on the Dow and S&P 500,...
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
Palantir, Nvidia, Eli Lilly, Symbotic, Tesla: Why These 5 Stocks Are On Investors' Radars Today
February 05, 2024
U.S. stocks traded lower at the end of trading on Monday with the Dow Jones Industrial Average declining 0.7% to 38,380.12.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Healthcare And Life Science Funds And ETFs Performance 2023-2024
February 05, 2024
Healthcare stocks usually provide a defensive posture to a stock portfolio.
Via
Talk Markets
Topics
ETFs
3 High-Octane Growth Stocks Not Slowing Down Any Time Soon
February 05, 2024
These high-octane growth stocks provide the kind of upside long-term investors should want from higher-risk bets.
Via
InvestorPlace
NVO, LLY or AZN: Which Pharma Stock Is the Best Weight-Loss Investment?
February 05, 2024
The relaunch of Wegovy last year caused a mad dash by weight loss stocks to compete for market leadership in anti-obesity drugs.
Via
InvestorPlace
Amgen Is Trying To Take On Lilly, Novo In Obesity Treatment — Here's Why Lilly Stock Just Hit A Record
February 05, 2024
Amgen is looking to rival Eli Lilly and Novo Nordisk in weight-loss drugs.
Via
Investor's Business Daily
Why Air Products and Chemicals Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
February 05, 2024
Shares of Air Products and Chemicals, Inc. (NYSE: APD) fell sharply during Monday’s session after the company reported worse-than-expected first-quarter financial results and lowered FY24 adjusted EPS...
Via
Benzinga
What's Going On With Eli Lilly Stock Today?
February 05, 2024
Eli Lilly's stock surge, driven by the upcoming Q4 2023 results and the impact of FDA-approved weight-loss drug Zepbound.
Via
Benzinga
Novo Nordisk To Up Production Capacity As Parent Buys Catalent
February 05, 2024
NVO stock rose after Novo Nordisk's parent, Novo Holdings, said it has agreed to buy contract manufacturer Catalent for $11.5 billion in cash.
Via
Investor's Business Daily
Estée Lauder Posts Upbeat Earnings, Joins ON Semiconductor, Tyson Foods And Other Big Stocks Moving Higher On Monday
February 05, 2024
U.S. stocks traded lower, with the Dow Jones falling over 300 points on Monday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Weight Loss Drug's New Entrant: Amgen To Compete With Novo Nordisk, Eli Lilly, As Investigational Weight Loss Drug Shows Encouraging Early Data
February 05, 2024
Amgen's AMG 133 data. Promising results in obesity drug trials, including significant weight loss and improved metabolic markers.
Via
Benzinga
< Previous
1
2
...
12
13
14
15
16
17
18
19
20
...
78
79
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.